Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
By enabling targeted, sustained, and controlled release of therapeutic agents, these platforms hold the promise to overcome the fundamental limitations of conventional intravitreal injections, such as rapid clearance and poor bioavailability
Promotes longer, synergistic anabolic windows Reduces catabolic rebound post-training or post-cycle IGF1 LR3 + BPC157 or TB500 Perfect for recovery, soft tissue repair, or bridging between cycles
Women often notice the downstream effects years before connecting them to growth hormone: sleep becomes lighter, recovery from exercise takes longer, body fat shifts toward the abdomen, and skin begins losing density
BDNF-Adjacent Pathways: While GHK-Cu does not directly upregulate BDNF (Brain-Derived Neurotrophic Factor), its anti-inflammatory effects in the CNS specifically its reduction of microglial activation may create conditions conducive to BDNF signaling
